CAH — Cardinal Health, Inc.
Healthcare Distributors · Founded 1971 · Dublin, Ohio · CEO: Jason Hollar
Cardinal Health is one of the three dominant U.S. pharmaceutical distributors and a major medical products company. Its pharmaceutical distribution segment provides drug logistics to health systems, retail pharmacies, and mail-order pharmacies. Its GMPD (Global Medical Products and Distribution) segment manufactures and distributes surgical supplies, exam gloves, and medical-surgical products. Cardinal Health spun off its specialty pharmaceutical distributor Specialty Networks and has been restructuring its medical products business to improve profitability.
How Cardinal Health, Inc. Makes Money
Pharmaceutical segment distribution fees and spread on drug wholesale distribution
GMPD segment revenue from manufacture and sale of branded and private-label medical products
Nuclear and precision health (Lantheus / Cardinal Health Specialty) radiopharmaceutical distribution
Services and other revenue from clinical intelligence solutions
Key Metrics Investors Watch
- Pharmaceutical segment profit growth and distribution fee retention
- GMPD segment margin recovery and improvement trajectory
- Specialty pharmaceutical business revenue
- Free cash flow and return to shareholders
- Debt management and leverage ratios
Competitive Advantages
- Cardinal Health nuclear pharmacy network distributes radiopharmaceuticals to hospitals daily
- Medical products manufacturing capability provides differentiation beyond pure distribution
- Scale and customer relationships across health systems and retail pharmacies create switching costs
- Downstream distribution integration reduces supply chain complexity for hospital customers
Key Risks
- Medical segment profitability has been under pressure from inflation and supply chain disruptions
- Pharmaceutical distribution margins face ongoing pressure from large customer negotiations
- Opioid settlement liability remains a legacy expense
- Competition from McKesson and Cencora across all major distribution lines
Dividend & Capital Return
Cardinal Health is a Dividend Aristocrat with decades of consecutive dividend increases, reflecting the company's historically consistent cash generation.
I Document Every Trade — Even the Losses
Options record: 1W-8L. Net worth: 100% GSE preferred. Get the unfiltered updates.
Unsubscribe anytime. I respect your inbox more than Congress respects property rights.
Frequently Asked Questions
What makes Cardinal Health different from McKesson?
Cardinal Health has a medical products manufacturing and distribution segment that gives it capabilities beyond pure drug distribution. Its nuclear pharmacy network is a specialized high-margin business. McKesson has its US Oncology Network practice management business as its key differentiator. This is educational content, not financial advice.
What is Cardinal Health's nuclear pharmacy business?
Cardinal Health operates the largest nuclear pharmacy network in the U.S., compounding and distributing radiopharmaceuticals (radioactive drugs used in PET scans and cancer treatment) to hospitals daily. These products have very short half-lives requiring delivery within hours of production. This is educational content, not financial advice.
Is Cardinal Health a Dividend Aristocrat?
Yes, Cardinal Health has increased its dividend for over 25 consecutive years, qualifying it as a Dividend Aristocrat. Its stable distribution business generates predictable cash flows supporting this streak. This is educational content, not financial advice.
Does Cardinal Health pay a dividend?
Yes, Cardinal Health is a Dividend Aristocrat with over 25 consecutive years of dividend increases, supported by the steady cash generation of its pharmaceutical distribution business. This is educational content, not financial advice.
What challenges has Cardinal Health's medical segment faced?
Cardinal Health's GMPD medical products segment experienced significant margin compression from supply chain inflation, PPE pricing normalization post-COVID, and operational inefficiencies. Management has been undertaking a multi-year profitability improvement program. This is educational content, not financial advice.
Related Stocks
Recommended Resources
Tools & books I actually use and recommend
SeekingAlpha Premium
Quant ratings, earnings transcripts, and the stock analysis community where I published 300+ articles.
Try SeekingAlphaThe Intelligent Investor
Ben Graham's timeless guide to value investing. The book Warren Buffett calls "the best investing book ever written."
View on AmazonInteractive Brokers
Low commissions, global market access, and professional-grade tools. This is where I hold my positions.
Open an AccountSome links above are affiliate links. I only recommend products I personally use. See my full disclosures.
Keep Exploring
All Stocks
Browse all 134 stock profiles by sector.
Read moreGuideBest Stocks For Beginners
Curated stock picks for new investors by goal.
Read moreReferenceFinancial Glossary
Understand the terms investors use every day.
Read moreCompareStock vs ETF
Individual stocks vs ETFs — which is right for you?
Read moreETFsETF Profiles
Deep dives on 90+ ETFs across every category.
Read moreGuideBuying Your First Stock
How to open a brokerage and buy your first share.
Read moreCompany information is based on publicly available disclosures and widely-known business facts. No specific price, earnings, or real-time market data is included. This is educational content — not investment advice.